Progress Pulse

Short summaries of scientific findings from across the St. Jude research enterprise.

Clinical Outcomes of Respiratory Syncytial Virus Infection Among Pediatric Immunocompromised Hosts

Learn how RSV can impact children with cancer.

Targeting oncofetal tenascin C with immunotherapy requires a signal boost

Adding activation signals improves solid and brain tumor immunotherapy.

Study links changes in the SMARCAL1 gene to increased risk for bone cancer

Researchers at St. Jude studying DNA damage repair genes have discovered a predisposition gene for osteosarcoma

St. Jude co-led multi-institution collaboration uncovers a predisposition gene for osteosarcoma

St. Jude scientists have discovered a new predisposition gene in a type of pediatric bone cancer.